封面
市场调查报告书
商品编码
1733946

嵌入式循环记录器的全球市场

Implantable Loop Recorders

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 376 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年,全球植入式循环记录器市场规模将达到 26 亿美元

全球嵌入式循环记录器市场规模预计在2024年为15亿美元,到2030年将达到26亿美元,2024年至2030年的复合年增长率为9.0%。手动嵌入式循环记录器是本报告分析的细分市场之一,预计其复合年增长率为10.3%,到分析期结束时市场规模将达到17亿美元。自动嵌入式循环记录器细分市场在分析期间的复合年增长率预计为6.9%。

美国市场规模估计为 4.173 亿美元,中国市场预计复合年增长率为 14.2%

美国植入式循环记录器市场规模预计在2024年达到4.173亿美元。预计到2030年,作为世界第二大经济体的中国市场规模将达到5.72亿美元,在2024-2030年的分析期内,复合年增长率为14.2%。其他值得关注的区域市场包括日本和加拿大,预计在分析期间内,这两个市场的复合年增长率分别为4.5%和8.7%。在欧洲,预计德国市场的复合年增长率约为6.1%。

全球嵌入式循环记录器市场-主要趋势与驱动因素摘要

哪些因素推动了植入式循环记录器在现代心臟病学中的临床相关性?

植入式循环记录器 (ILR),又称为可插入式心臟监视器 (ICM),彻底革新了长期心律监测,能够实现长达三年的持续心电图监测。这些皮下装置尤其适用于诊断间歇性心律不整,例如隐源性晕厥、隐源性中风和阵发性心房颤动。与传统的心电图监测和体外事件记录仪不同,ILR 消除了短期资料收集的限制以及患者对穿戴式电极的违规。即使是无症状患者,不间断的心臟监测也能显着提高诊断率,尤其是在心律不整发作罕见或难以预测的情况下。

美国心臟病学会 (AHA) 和欧洲心臟病学会 (ESC) 的临床指南越来越多地推荐 ILR 作为不明原因晕厥或短暂性意识丧失患者的一线治疗方案,进一步证明了其在心臟诊断领域的地位。 ILR 的应用范围不仅限于晕厥,也越来越多地用于评估中风后不明原因事件,而未检测到的心房颤动可能是这些事件的潜在诱因。这些设备在长期监测遗传性心律不整症候群患者以及心房颤动消融术后復发性心房颤动方面也显示出巨大的价值,从而扩大了其在普通心臟病学和电生理学亚专科中的效用。

技术进步如何改变嵌入式循环记录器的格局?

近年来,ILR 设计和资料处理能力不断创新。新一代设备体积越来越小,方便进行微创门诊植入手术。例如,现在的设备体积小于一立方厘米,植入时间不到五分钟。这些更小巧的外形规格不仅提高了患者的舒适度,还降低了手术风险和医疗保健系统的成本。电池寿命也显着提升,大多数设备现在无需更换即可使用 3-4 年。

在数位化方面,远端远端检测系统与智慧型手机患者应用程式的整合显着改善了即时数据存取和临床工作流程。医生现在可以收到心臟收缩、心搏过缓心房颤动等关键事件的即时警报,以便更早介入。同时,人工智慧和机器学习演算法正在被嵌入到云端基础平台中,以减少误报并自动识别大型资料集中的模式。这些功能在远端患者监护计画、远距心臟病学服务以及传统临床环境以外的慢性病族群管理中尤其有益。

采用热点和扩大临床应用有哪些?

目前,北美和欧洲凭藉着完善的报销政策、强大的临床基础设施以及远端监控技术的早期整合,在全球 ILR 的采用率方面处于领先地位。然而,由于心臟诊断服务的普及、对心房颤动相关中风的认识提高以及公共对心臟健康的投入增加,亚太和拉丁美洲等新兴市场的植入数量正在增加。各国政府和保险公司也开始意识到 ILR 在降低復发性住院和中风相关残疾方面的成本效益。

在临床应用方面,虽然晕厥诊断仍是主要指征,但 ILR 在中风二级预防计画的普及度正在迅速提升。许多卒中中心正在将 ILR 纳入其诊断方案中,以检测隐源性阵发性心房颤动,这是一种常见但未被充分诊断​​的栓塞性中风原因。此外,ILR 在电生理研究中的消融后监测以及结构性心臟病的管理中的作用正在不断扩大,尤其是在植入心臟起搏器或心臟导管室 (CRT) 等心臟装置的患者中,它能够提供辅助诊断依据。儿科心臟病学是另一个前沿领域,ILR 在评估年轻族群遗传性心律不整方面正日益受到关注,儘管出于解剖和操作方面的考虑,需要谨慎的选择标准。

嵌入式循环记录器市场的成长受到多种因素的推动。

首先,设备小型化和微创插入技术的不断创新显着降低了高所得和中等收入国家的采用门槛。这为其在门诊和以地区为基础心臟护理模式中的应用开闢了新的途径。其次,远端监控技术与云端基础分析平台的整合使ILR成为一种互联医疗工具,这与全球向数位化医疗、分散式医疗和远端监控的转变相契合。这些进步使循环系统能够有效率地管理更大的患者群体,同时保持诊断的准确性。

第三,不断扩大的临床使用案例,特别是中风诊断、心房颤动监测、心房颤动消融后监测、遗传性心律不整检测等,正在增加可寻址患者群体。此外,美国、德国和日本等主要市场的支持性报销政策对于推动医生采用和患者可及性至关重要。第四,全球心血管疾病(主要是心房颤动和中风)的增加,推动了对早期和可靠心律诊断的需求,从而产生了对 ILR 的持续需求。最后,由于人们认识的提高、心臟病学基础设施的改善以及主要设备製造商的有针对性的销售策略,这些设备在新兴地区的供应增加也推动了市场的成长。

部分

产品(手动产品、自动产品)、适应症(心血管晕厥适应症、中风适应症、心臟衰竭适应症、心律不整适应症、心房颤动适应症、束支传导阻滞适应症、其他适应症)、最终用户(医院最终用户、心臟中心和诊所最终用户、门诊手术中心最终用户)

受访公司范例(总合34家)

  • Abbott Laboratories
  • Angel Medical Systems, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Insight, Inc.
  • Cardiovascular Systems, Inc.
  • ConMed Corporation
  • Cook Medical
  • GE Healthcare
  • HeartWare International, Inc.
  • Hill-Rom Holdings, Inc.
  • iRhythm Technologies, Inc.
  • Koninklijke Philips NV
  • LifeWatch Technologies
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Preventice Solutions
  • ProgenyHealth

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口(成品和原始OEM)来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手,包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家(14,949位)、智库(62家)以及贸易和产业协会(171家)的专家的意见,以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计,这场动盪将在未来2-3个月内逐渐平息,新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月:谈判阶段

在4月的报告中,我们将探讨关税对全球整体市场的影响,并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月:最终关税调整

在各国宣布最终重置后,客户将在 7 月收到免费更新,最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析:

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家:全球产业分析师知识库追踪了 14,949 位经济学家,其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家,他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP33960

Global Implantable Loop Recorders Market to Reach US$2.6 Billion by 2030

The global market for Implantable Loop Recorders estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. Manual Implantable Loop Recorders, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Automatic Implantable Loop Recorders segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$417.3 Million While China is Forecast to Grow at 14.2% CAGR

The Implantable Loop Recorders market in the U.S. is estimated at US$417.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$572.0 Million by the year 2030 trailing a CAGR of 14.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Implantable Loop Recorders Market - Key Trends & Drivers Summarized

What Is Driving the Clinical Relevance of Implantable Loop Recorders in Modern Cardiology?

Implantable loop recorders (ILRs), also known as insertable cardiac monitors (ICMs), have revolutionized long-term cardiac rhythm monitoring by enabling continuous ECG surveillance for up to three years. These subcutaneous devices are particularly valuable in diagnosing unexplained syncope, cryptogenic stroke, and intermittent arrhythmias, such as paroxysmal atrial fibrillation. Unlike traditional Holter monitors or external event recorders, ILRs eliminate the limitations of short-term data capture and patient non-compliance with wearable electrodes. This ability to provide uninterrupted cardiac monitoring, even in asymptomatic patients, significantly enhances diagnostic yield, especially in cases where arrhythmic episodes are infrequent or unpredictable.

Clinical guidelines from the American Heart Association (AHA) and European Society of Cardiology (ESC) increasingly recommend ILRs as first-line tools in patients with unexplained syncope or transient loss of consciousness, further legitimizing their place in cardiac diagnostic pathways. Beyond syncope, there is growing utilization of ILRs in post-stroke evaluation for cryptogenic causes, where undetected atrial fibrillation may be an underlying factor. These devices are also proving critical in long-term monitoring for patients with inherited arrhythmia syndromes or post-ablation monitoring for recurrence of atrial fibrillation, expanding their utility in both general cardiology and electrophysiology subspecialties.

How Are Technology Advancements Reshaping the Implantable Loop Recorder Landscape?

The past few years have witnessed rapid innovation in ILR design and data handling capabilities. New-generation devices are increasingly miniaturized, facilitating minimally invasive insertion procedures that can be performed in outpatient settings. For instance, some devices now measure less than 1 cubic centimeter in volume and can be implanted in under five minutes. These miniaturized form factors not only improve patient comfort but also reduce procedural risk and cost burden on healthcare systems. Battery longevity has also improved significantly, with most devices now lasting between three and four years without replacement.

On the digital front, integration with remote telemetry systems and smartphone-compatible patient apps has dramatically improved real-time data access and clinical workflow. Physicians can now receive instant alerts for critical events such as asystole, bradycardia, or atrial fibrillation episodes, enabling earlier interventions. In parallel, artificial intelligence and machine learning algorithms are being embedded into cloud-based platforms to reduce false positives and automate pattern recognition across large datasets. These capabilities are especially beneficial in remote patient monitoring programs, telecardiology services, and in managing chronic disease populations outside traditional clinical settings.

Where Are the Adoption Hotspots and Which Clinical Applications Are Expanding?

North America and Europe currently lead global ILR adoption, driven by well-established reimbursement policies, strong clinical infrastructure, and early integration of remote monitoring technologies. However, emerging markets in Asia-Pacific and Latin America are witnessing a rise in implant volumes due to improved access to cardiac diagnostics, rising awareness of atrial fibrillation-related stroke, and increased investment in public cardiac health initiatives. Governments and insurers are also starting to recognize the cost-effectiveness of ILRs in reducing recurrent hospitalizations and stroke-related disability.

In terms of clinical use, while syncope diagnosis remains the leading indication, ILRs are seeing rapid uptake in secondary stroke prevention programs. Many stroke centers are incorporating ILRs into their diagnostic workup to detect occult paroxysmal atrial fibrillation-a common but underdiagnosed cause of embolic strokes. Furthermore, their role is expanding in electrophysiology for post-ablation surveillance and in structural heart disease management, particularly among patients with implanted cardiac devices like pacemakers or CRTs, where ILRs provide adjunctive diagnostic insights. Pediatric cardiology is another frontier, where ILRs are gaining interest for evaluating inherited rhythm disorders in younger populations, albeit with careful selection criteria due to anatomical and procedural considerations.

The Growth in the Implantable Loop Recorders Market Is Driven by Several Factors…

First, continuous innovation in device miniaturization and minimally invasive insertion techniques has significantly lowered the threshold for adoption across both high- and middle-income countries. This has opened new avenues for use in ambulatory and community-based cardiac care models. Second, the integration of remote monitoring technologies and cloud-based analytics platforms has turned ILRs into connected health tools, aligning well with the global shift toward digital health, decentralized care, and telemonitoring. These advancements allow cardiologists to efficiently manage larger patient cohorts while maintaining diagnostic precision.

Third, the expanding clinical use cases-particularly in cryptogenic stroke diagnostics, atrial fibrillation surveillance, post-ablation monitoring, and inherited rhythm disorder detection-are collectively enlarging the addressable patient pool. Additionally, supportive reimbursement policies in key markets such as the U.S., Germany, and Japan have been critical in driving both physician adoption and patient access. Fourth, rising global cardiovascular disease prevalence, especially atrial fibrillation and stroke, is fueling the need for early and reliable rhythm diagnostics, creating sustained demand for ILRs. Finally, market growth is also bolstered by the increasing availability of these devices in emerging regions, thanks to growing awareness, improving cardiology infrastructure, and targeted distribution strategies by leading device manufacturers.

SCOPE OF STUDY:

The report analyzes the Implantable Loop Recorders market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Manual Product, Automatic Product); Indication (Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication, Other Indications); End-User (Hospitals End-User, Cardiac Centers & Clinics End-User, Ambulatory Surgery Centers End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Angel Medical Systems, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Insight, Inc.
  • Cardiovascular Systems, Inc.
  • ConMed Corporation
  • Cook Medical
  • GE Healthcare
  • HeartWare International, Inc.
  • Hill-Rom Holdings, Inc.
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • LifeWatch Technologies
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Preventice Solutions
  • ProgenyHealth

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Implantable Loop Recorders - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Atrial Fibrillation and Unexplained Syncope Spurs Demand for Continuous Cardiac Monitoring
    • Growing Emphasis on Early Diagnosis of Cardiac Arrhythmias Propels Adoption of Implantable Loop Recorders
    • Increasing Geriatric Population Base Strengthens Business Case for Long-Term Cardiac Monitoring Solutions
    • Technological Advancements in Miniaturization and Battery Life Extend Device Usability and Drive Market Expansion
    • Integration of Remote Monitoring Capabilities Enhances Care Continuity and Accelerates Demand for Smart ILRs
    • Rising Use of AI and Predictive Analytics in Cardiac Monitoring Expands the Value Proposition of ILR Devices
    • Expansion of Outpatient Cardiac Monitoring Programs Throws the Spotlight on Cost-Effective ILR Solutions
    • Increasing Cardiac Monitoring Adoption Across Emerging Economies Expands Global Addressable Market Opportunity
    • Shift Toward Minimally Invasive and Ambulatory Monitoring Procedures Drives Preference for ILRs Over Holter Monitors
    • Growing Investments in Cardiac Telehealth Infrastructure Sustain Growth Momentum in Remote ILR Services
    • Rising Clinical Use of ILRs in Unexplained Strokes Expands Indications and Supports Market Growth
    • Growing Role of Digital Health Ecosystems Facilitates Seamless Data Integration and Boosts Adoption Rates
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Implantable Loop Recorders Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Manual Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Manual Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Manual Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Automatic Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Automatic Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Automatic Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiac Centers & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cardiac Centers & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cardiac Centers & Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiovascular Syncope Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiovascular Syncope Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiovascular Syncope Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Stroke Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Heart Failure Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Heart Failure Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Heart Failure Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cardiac Arrhythmia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cardiac Arrhythmia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Cardiac Arrhythmia Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Atrial Fibrillation Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Atrial Fibrillation Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Atrial Fibrillation Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Bundle Branch Block Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Bundle Branch Block Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Bundle Branch Block Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • JAPAN
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • CHINA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • EUROPE
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Implantable Loop Recorders by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • FRANCE
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • GERMANY
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Implantable Loop Recorders by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • INDIA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Implantable Loop Recorders by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Implantable Loop Recorders by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • AFRICA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION